Because of Jeff's personal experience with this medical technology, he believes it can change the world: "it's an extraordinary new pattern in medication driven by technology that identified cancer. And gave me a battling possibility to beat it extremely early before it turned into a possibly deadly problem." Jeff doesn't simply suggest investing in this company to take advantage of this trend.
: "But there's more to this innovation than just conserving my life. By subscribing to The Near Future Report today, you can find how this innovation works, what it does, and why Jeff believes it will change the world of medicine.
"There's Biolife Sciences, which rose as high as 41,800% in less than a year, A little, $1,000 stake might have restored as much as $418,000." The sales page is filled with comparable gains. Jeff Brown utilizes Mirati Therapies as an example, which rose 8,481% in under two years. Other gains included on The Near Future Report's sales page consist of: Jeff Brown bewares to explain that past revenues do not ensure future results.
He does not recommend assigning a considerable part of your portfolio to these stocks. Nevertheless, Jeff also declares he has actually "checked out suppliers and done his own research on future revenues" to confirm his suggestions. Based upon that analysis, Jeff is confident that a few of his biotech stock choices will rise considerably in the near future.
2 Trillion Industry that Could Save Millions of Lives? Jeff, like many financiers, believes biotech will be one of the hottest tech trends over the coming years. Biotech is no secret.
Jeff discusses precision medicine as one example: "the biotech market is anticipated to grow 86% over the next couple of years. That is impressive. But listen to this, The precision medication market is anticipated to grow 152% throughout that exact same time" Precision medicine is an emerging area of biotech that uses accurate biological data to calculate disease threat.
